Funded Startups in San Sebastian
Among the 12 most recent funded startups listed for San Sebastian, the largest disclosed round stands out clearly: cimico’s $8M (2023-07-18).
Among the 12 most recent funded startups listed for San Sebastian, the largest disclosed round stands out clearly: cimico’s $8M (2023-07-18). The rest of the disclosed amounts cluster below that level, including two $5M rounds from Irisbond ($5M on 2025-03-20) and CounterCraft ($5M on 2020-06-17), plus smaller disclosed figures like BioTech Foods ($760K on 2022-09-12) and Deneb Medical ($300K on 2022-04-08). The list also shows a tight temporal band in mid-2023: three entries fall in July 2023 (cimico on 2023-07-18, Cyber Surgery on 2023-07-12) with another nearby date (InspectRail on 2024-03-01 is outside that window), suggesting bursts rather than steady arrivals.
Sector-wise, there’s no single sector dominating across many rows; counts are spread across biotechnology/pharma (Miramoon Pharma), environmental services (cimico), hardware (Cyber Surgery), and information technology (Smowltech, CounterCraft). Stage and disclosure are also uneven: 4 of 12 rows are marked “undisclosed” (Miramoon Pharma 2025-11-18; Cyber Surgery 2023-07-12; Smowltech 2023-01-24; Deneb Medical 2022-04-08), and 5 of 12 are labeled “Series Unknown”/blank stage designations (Irisbond is Series Unknown; cimico is Series Unknown; Smowltech is Series Unknown; EPowerlabs is Series Unknown; DeltaComGroup is “Venture - Series Unknown”). Dates span 2020-06-17 to 2025-11-18, with the most recent entry being Miramoon Pharma on 2025-11-18.
Most recent rounds
12 shownRelated listings
Frequently asked
What’s the largest disclosed round in this San Sebastian set, and how do the other disclosed amounts compare?
The largest disclosed amount is cimico’s $8M on 2023-07-18. The next-highest disclosed amounts are $5M (Irisbond on 2025-03-20 and CounterCraft on 2020-06-17), while the remaining disclosed rounds include $3M (EPowerlabs on 2022-12-01) and sub-$1M figures like BioTech Foods’ $760K on 2022-09-12.
Do disclosures and stage labels cluster in a way that limits comparability?
Yes. 4 of 12 rows show “undisclosed” amounts (Miramoon Pharma 2025-11-18; Cyber Surgery 2023-07-12; Smowltech 2023-01-24; Deneb Medical 2022-04-08), and another 5 of 12 use “Series Unknown”/blank stage designations (e.g., Irisbond 2025-03-20; cimico 2023-07-18; EPowerlabs 2022-12-01; DeltaComGroup 2021-08-12; Smowltech 2023-01-24).
Are there any notable bursts in the recent timeline shown?
The list shows a mid-2023 cluster with two July 2023 entries close together: Cyber Surgery on 2023-07-12 and cimico on 2023-07-18. Beyond that, the span is more spread out from 2020-06-17 (CounterCraft) through 2025-11-18 (Miramoon Pharma), rather than concentrated in a single short window.
Which stage classifications appear most often among the 12 rows?
Seed appears twice: Beseif ($400K on 2021-09-07) and Miramoon Pharma (undisclosed amount on 2025-11-18). Grant appears once (BioTech Foods, $760K on 2022-09-12), while Series Unknown/other labels account for most remaining entries, including Irisbond (Series Unknown, $5M on 2025-03-20) and DeltaComGroup (Venture - Series Unknown, $400K on 2021-08-12).
Are there outliers in disclosed funding size worth a closer look?
cimico’s $8M (2023-07-18) is the clear top-end outlier in disclosed amounts, well above the $5M level (Irisbond 2025-03-20; CounterCraft 2020-06-17) and above $3M (EPowerlabs 2022-12-01). At the low end of disclosed amounts, Deneb Medical is $300K on 2022-04-08, while multiple other entries are undisclosed, which may mask additional low/high tail behavior.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.